Hypotension following treatment with aerosolized colistin in a patient with multidrug-resistant Pseudomonas aeruginosa

Annals of Pharmacotherapy

Volumn 40, Issue 9, 2006, Pages 1677-1680

  Hakeam, Hakeam A ^a   Almohaizeie, Abdullah M ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Aerosolized; Amikacin; Colistin; Hypotension; Polymyxin

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; COLISTIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CASE REPORT; CRITICAL ILLNESS; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; HUMAN; HYPOTENSION; INTENSIVE CARE; MALE; MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA; PRIORITY JOURNAL; PROBABILITY; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; SEPTIC SHOCK;

ADMINISTRATION, INHALATION; AEROSOLS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 33748295688     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H019     Document Type: Article

References (20)

1. Bessalle R, Gorea A, Shalit I, Metzger JW, Dass C, Desiderio DM. Structure-function studies of amphiphilic antibacterial peptides. J Med Chem 1993;36:1203-9.
2. Li J, Turnidge J, Milne R, Nation RL, Coulthard K. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 2001;45:781-5.
3. Catchpole CR, Andrews JM, Brenwald N, Wise R. A reassessment of the in-vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 1997;39:255-60.
4. Jensen T, Pedersen SS, Garne S, Heilmann C, Hoiby N, Koch C. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 1987;19:831-8.
5. Hodson ME, Gallagher CG. New clinical evidence from the European tobramycin trial in cystic fibrosis. J Cyst Fibros 2002;1(suppl):S199-202.
6. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005;9:29-30.
7. Hamer DH. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudonomas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 2000;162:328-30.
8. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 1970;72: 857-68.
9. Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005;11:115-21.
10. Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 2003;37:e154-60.
11. Palmer LB, Smaldone GC, Simon SR, O'Riordan TG, Cuccia A. Aerosolized antibiotics in mechanically ventilated patients: delivery and response. Crit Care Med 1998;26:31-9.
12. Beringer P. The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulm Med 2001;7:434-40.
13. Bauldoff GS, Nunley DR, Manzetti JD, Dauber JH, Keenan RJ. Use of aerosolized colistin sodium in cystic fibrosis patients awaiting lung transplantation. Transplantation 1997;64:748-52.
14. Maddison J, Dodd M, Webb AK. Aerosolized colistin causes chest tightness in adults with cystic fibrosis. Respir Med 1994;88:145-7.
15. Wood GC, Boucher BA. Aerosolized antimicrobial therapy in acutely ill patients. Pharmacotherapy 2000;20:166-81.
16. Sasaki S, Mitsuhashi Y, Kondo S. Contact dermatitis due to sodium colistimethate. J Dermatol 1998;25:415-7.
17. Jasani B, Kreil G, Mackler BF, Stanworth DR. Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells. Biochem J 1979;181:623-32.
18. Jones A, Elphick H, Pettitt E, Everard ML, Evans GS. Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase. Eur Respir J 2002;19:1136-41.
19. Shin YH, Akaike T, Khan MM, Sakata Y, Maeda H. Further evidence of bradykinin involvement in septic shock: reduction of kinin production in vivo and improved survival in rats by use of polymer tailored SBTI with longer 11/2. Immunopharmacology 1996;33:369-73.
20. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.